Histogen Inc. Profile Avatar - Palmy Investing

Histogen Inc.

Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clini…

Biotechnology
US, San Diego [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of HSTO's Analysis
CIK: 1383701 CUSIP: 43358Y103 ISIN: US43358Y2028 LEI: - UEI: -
Secondary Listings
HSTO has no secondary listings inside our databases.